Atypical evolution of meningiomatosis after discontinuation of cyproterone acetate: clinical cases and histomolecular characterization-Reference-Cited by-同舟云学术

Atypical evolution of meningiomatosis after discontinuation of cyproterone acetate: clinical cases and histomolecular characterization

Published:2021-10-06 Issue:1 Volume:164 Page:255-263
ISSN:0001-6268
Container-title:Acta Neurochirurgica
language:en
Short-container-title:Acta Neurochir

Author:

Passeri Thibault^ORCID,Giammattei Lorenzo,Le Van Tuan,Abbritti Rosaria,Perrier Alexandre,Wong Jennifer,Bourneix Christine,Polivka Marc,Adle-Biassette Homa,Bernat Anne-Laure,Masliah-Planchon Julien,Mandonnet Emmanuel,Froelich Sébastien

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Surgery

Link

https://link.springer.com/content/pdf/10.1007/s00701-021-05005-9.pdf

Reference47 articles.

1. Abedalthagafi M, Bi WL, Aizer AA et al (2016) Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro-Oncol 18(5):649–655

2. Banan R, Hartmann C (2017) The new WHO 2016 classification of brain tumors-what neurosurgeons need to know. Acta Neurochir (Wien) 159(3):403–418

3. Batchinsky-Parrou V, Barraud S, Kleiber JC, Litre F (2021) First case of cyproterone acetate induced multiple meningiomas in identical female twins: a case report. Neurochirurgie. https://doi.org/10.1016/j.neuchi.2021.04.021

4. Bergoglio MT, Gómez-Balaguer M, Almonacid Folch E, Hurtado Murillo F, Hernández-Mijares A (2013) Symptomatic meningioma induced by cross-sex hormone treatment in a male-to-female transsexual. Endocrinol Nutr 60(5):264–267

5. Bernat AL, Bonnin S, Labidi M, Aldahak N, Bresson D, Bouazza S, Froelich S (2018) Regression of giant olfactory groove meningioma and complete visual acuity recovery after discontinuation of cyproterone acetate. J Ophthalmic Vis Res 13(3):355–358

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prolonged use of nomegestrol acetate and risk of intracranial meningioma: a population-based cohort study;The Lancet Regional Health - Europe;2024-07

2. Hormone therapies in meningioma-where are we?;Journal of Neuro-Oncology;2022-11-23

3. Risk of intracranial meningioma with three potent progestogens: A population‐based case–control study;European Journal of Neurology;2022-06-20

4. Cyproterone;Reactions Weekly;2022-02

5. Correction to: Atypical evolution of meningiomatosis after discontinuation of cyproterone acetate: clinical cases and histomolecular characterization;Acta Neurochirurgica;2021-11-09